International Journal of Molecular Sciences · 2023 · 24 citations · 29 references
PharmacyPharmacokineticsPharmacologyDrug DeliveryMolecular ImagingTargeted Drug DeliveryNanomedicineTargeted Cancer TherapyDrug Retention TimeFluorophore DesignHumanized Xenograft ModelsMolar Extinction CoefficientMolecular TargetingOrthotopic Tumor ModelsTargeted Molecular Imaging AgentsTumor Targeting Ligands
Small molecule fluorophores often face challenges such as short blood half-life, limited physicochemical and optical stability, and poor pharmacokinetics. To overcome these limitations, we conjugated the zwitterionic near-infrared fluorophore ZW800-PEG to human serum albumin (HSA), creating HSA-ZW800-PEG. This conjugation notably improves chemical, physical, and optical stability under physiological conditions, addressing issues commonly encountered with small molecules in biological applications. Additionally, the high molecular weight and extinction coefficient of HSA-ZW800-PEG enhances biodistribution and tumor targeting through the enhanced permeability and retention effect. The unique distribution and elimination dynamics, along with the significantly extended blood half-life of HSA-ZW800-PEG, contribute to improved tumor targetability in both subcutaneous and orthotopic xenograft tumor-bearing animal models. This modification not only influences the pharmacokinetic profile, affecting retention time and clearance patterns, but also enhances bioavailability for targeting tissues. Our study guides further development and optimization of targeted imaging agents and drug-delivery systems.
29
Renal clearance of quantum dots
Hak Soo Choi, Wenhao Liu, Preeti Misra et al. · Nature Biotechnology · 2007 · 4.4K citations · Full text
Susan L. Troyan, Vida Kianzad, Summer L. Gibbs‐Strauss et al. · Annals of Surgical Oncology · 2009 · 681 citations · Full text